- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 237
Solazyme plans $100m flotation
Solazyme, a US-based developer of biofuels through the use of algae, said it had raised $129.3m in equity and its strategic investors were Bunge, Chevron, Unilever and San-Ei Gen ahead of its $100m flotation.
Mar 15, 2011Fusion-io preps $150m flotation
Investment banks Goldman Sachs, Morgan Stanley, JP Morgan and Credit Suisse are underwriting Fusion-io's initial public offering, according to its regulatory filing.
Mar 11, 2011Advanced BioHealing preps flotation
Safeguard owns 1.59 million shares, 28.1% of Advanced BioHealing ahead of its Nasdaq flotation, while venture capital firms Canaan Partners and Wheatley Partners own 40.7% and 14.7%, respectively.
Mar 1, 2011Oak Pacific preps $500m flotation
Newswire Bloomberg said Oak's $500m initial public offering could come by the summer and was backed by computer group Lenovo's corporate venturing unit Legend Capital and Japanese media group Softbank as well as venture capital firms Technology Crossover Ventures, Accel Partners, and Doll Capital Management.
Feb 24, 2011HomeAway preps flotation
Newswire Bloomberg said HomeAway's flotation would be for up to $300m and managed by investment banks Morgan Stanley, Deutsche Bank, JPMorgan Chase and Goldman Sachs.
Feb 23, 2011Pandora Media preps flotation
In August, Pandora had been reportedly about to raise $100m from private equity firm Elevation Partners, according to news provider TechCrunch, but instead has picked investment banks Morgan Stanley and JP Morgan to plan its initial public offering, according to its regulatory filing.
Feb 16, 2011Active Network stays fit for flotation
Active Network has raised more than $275m, according to news provider Fortune, and has Ticketmaster and Disney as two primary shareholders.
Feb 15, 2011Fluidigm floats at range bottom
Fluidigm raised $75m at $13.50 per share by selling 5.6 million shares, with a further 833,750 available if demand is strong enough for its investment banks Deutsche Bank and Piper Jaffray, according to its regulatory filing.
Feb 13, 2011AcelRx halves flotation
AcelRx had planned to raise $86m in its initial public offering (IPO) but is now offering eight million shares at $5 each, with a further 1.2 million available if there is enough demand, according to its regulatory filing.
Feb 13, 2011Gevo fuels $100m flotation
The company sold 7.15 million common shares at its initial public offering (IPO) at $15 each, according to Gevo's regulatory filing.
Feb 13, 2011About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


